Latest News and Press Releases
Want to stay updated on the latest news?
-
RESEARCH TRIANGLE PARK, N.C., Jan. 18, 2022 (GLOBE NEWSWIRE) -- Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research organization...
-
LOS ANGELES, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Science 37, Inc. (Nasdaq: SNCE), the Agile Clinical Trial Operating System, today announced it has added capability to meet regulatory requirements and...
-
LOS ANGELES, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (“Science 37”), pioneer of decentralization and Operating System for today’s more agile clinical trials™, has...
-
LOS ANGELES, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), (“Science 37”) the Operating System for today’s more agile clinical trials, today reported its financial...
-
LOS ANGELES, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE), the Operating System for today’s more agile clinical trials, today announced it will report third quarter...
-
LOS ANGELES and TOKYO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Science 37, the Operating System for today’s more agile clinical trials, and CMIC HOLDINGS Co., Ltd. (“CMIC”), the largest CRO in Japan today...
-
LOS ANGELES and TOKYO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Science 37, the Operating System for today’s more agile clinical trials and 3H Medi Solution Inc., a clinical trials solution leader in Japan...
-
LOS ANGELES, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Science 37, the Operating System for today’s more agile clinical trials, announced Elisa Cascade has joined Science 37 and its senior executive team as...
-
With this important addition to its Board of Directors, Science 37 further advances its mission to accelerate clinical trials by enabling universal access to patients and providers. LOS ANGELES, Oct....
-
Science 37 to debut on Nasdaq as a publicly traded company under ticker symbol “SNCE”Business combination will provide Science 37 with approximately $235 million in cash proceeds to support continued...